Methods
The PROGRESS trial was a blinded, placebo-controlled trial of a flexible antihypertensive regimen based on perindopril and the diuretic indapamide. 6105 patients with a history of stroke or TIA and were randomised to treatment or placebo.
Active treatment consisted of 4 mg perindopril daily with indapamide at the discretion of the duty physician. Placebo tablets were identical.
The primary outcome was recurrent stroke, fatal and non-fatal. Analysis was by intention to treat.
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.